These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4073869)

  • 1. Pharmacokinetics of cephalosporins in normal and septicemic rabbits.
    Ganzinger U; Haslberger A
    Antimicrob Agents Chemother; 1985 Oct; 28(4):473-7. PubMed ID: 4073869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of endotoxin on the distribution of cephalosporins in rabbits.
    Ganzinger U; Haslberger A; Schiel H; Omilian-Rosso R; Schütze E
    J Antimicrob Chemother; 1986 Jun; 17(6):785-93. PubMed ID: 3733592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of pharmacokinetic properties of gentamicin, penicillin G and two cephalosporins in septicaemic rabbits.
    Haslberger AG; Ganzinger U; Reiter H; Schiel H; Millendorfer A
    J Antimicrob Chemother; 1987 Aug; 20(2):273-82. PubMed ID: 3667483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of serum protein binding and mode of administration on penetration of five cephalosporins into subcutaneous tissue fluid in humans.
    Hoffstedt B; Walder M
    Antimicrob Agents Chemother; 1981 Dec; 20(6):783-6. PubMed ID: 7325644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
    Lüthy R; Blaser J; Bonetti A; Simmen H; Wise R; Siegenthaler W
    Antimicrob Agents Chemother; 1981 Nov; 20(5):567-75. PubMed ID: 6275776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetic analysis of latamoxef and CPW 86-363, a novel carboxy-pyrazol-cephalosporin and formation of N-methyl-thiotetrazole.
    Ganzinger U; Schatz F; Haberl H; Haslberger A; Schiel H; Hitzenberger G
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):152-6. PubMed ID: 3557743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
    McCracken GH; Nelson JD; Grimm L
    Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.
    Wise R; Baker S; Livingston R
    Antimicrob Agents Chemother; 1980 Sep; 18(3):369-71. PubMed ID: 6252833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of a new semisynthetic cephalosporin (AL-226) in rabbits.
    Dominguez-Gil AA; Cepeda M; Vila JL; Garcia JJ
    J Antibiot (Tokyo); 1979 May; 32(5):482-7. PubMed ID: 528394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkeys.
    Matsui H; Yano K; Okuda T
    Antimicrob Agents Chemother; 1982 Aug; 22(2):213-7. PubMed ID: 6927282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of SK&F 88070, an expanded-spectrum cephalosporin with high and prolonged levels in blood.
    Grappel SF; Phillips L; Dunn GL; Jakas DR; Pitkin D; Actor P
    Antimicrob Agents Chemother; 1984 Jun; 25(6):694-700. PubMed ID: 6742815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusibility of the newer cephalosporins into human interstitial fluids.
    Tan JS; Salstrom SJ; File TM
    Am J Med; 1984 Oct; 77(4C):33-6. PubMed ID: 6093516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.
    Gerding DN; Peterson LR; Legler DC; Hall WH; Schierl EA
    Antimicrob Agents Chemother; 1978 Aug; 14(2):234-9. PubMed ID: 697350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ceftizoxime in animals after parenteral dosing.
    Murakawa T; Sakamoto H; Fukada S; Nakamoto S; Hirose T; Itoh N; Nishida M
    Antimicrob Agents Chemother; 1980 Feb; 17(2):157-64. PubMed ID: 6770752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
    Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological perfusion model for cephalosporin antibiotics I: Model selection based on blood drug concentrations.
    Greene DS; Quintiliani R; Nightingale CH
    J Pharm Sci; 1978 Feb; 67(2):191-6. PubMed ID: 621635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits.
    Gerding DN; Hall WH; Schierl EA; Manion RE
    Antimicrob Agents Chemother; 1976 Dec; 10(6):902-11. PubMed ID: 1008548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects.
    Peterson LR; Bean B; Fasching CE; Korchik WP; Gerding DN
    Antimicrob Agents Chemother; 1981 Sep; 20(3):378-81. PubMed ID: 6458235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.